The Chicago Entrepreneur

: Moderna is the latest company to produce a promising RSV vaccine

The experimental respiratory syncytial virus vaccine prevented most infections in older adults in a Phase 3 clinical trial

Previous post Deep Dive: Here’s why Citigroup’s stock stands out among the biggest U.S. banks
Next post Amid inflation, more middle-class Americans struggle to make ends meet